Company Search:
Advanced Search
Sponsored Links
Hypera SA - ADR Company Snapshot
Hypera SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other companies in this sector in UNITED STATES : Indivior Plc (2019 sales of $785.00 million of which 100% was Buprenorphine Based Drugs), Arena Pharmaceuticals, Inc. ($806.43 million of which 100% was Drug Discovery & Development), and Phibro Animal Health Corp ($828.00 million of which 64% was Animal Health).

Sales Analysis. Hypera SA reported sales of $835.52 million for the year ending December of 2019. This represents a decrease of 17.9% versus 2018, when the company's sales were $1.02 billion.
  Stock Performance Chart for Hypera SA - ADR
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 5.53
(Figures in U.S. Dollars)
1 Week -0.9%   13 Weeks -12.2%  
4 Weeks -9.3%   52 Weeks -30.4%  
Hypera SA - ADR Key Data:
  Ticker: HYPMY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 835,515,399
(Year Ending Jan 2020).
Employees: 7,515
  Currency: U.S. Dollars Market Cap: 3,495,152,632
  Fiscal Yr Ends: December Shares Outstanding: 632,034,834
  Share Type: Common Closely Held Shares: 266,837,433
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.